Graham Capital Management, L.P. Becton Dickinson & CO Transaction History

Graham Capital Management, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$225.07 - $246.17 $4.46 Million - $4.87 Million	19,801 Added 195.55%	29,927 $6.99 Million
Q1 2024 May 15, 2024	BUY	$233.45 - $247.73 $2.1 Million - $2.22 Million	8,981 Added 784.37%	10,126 $2.51 Million
Q4 2023 Feb 14, 2024	BUY	$232.24 - $267.23 $265,914 - $305,978	1,145 New	1,145 $279,000
Q3 2021 Nov 15, 2021	SELL	$232.72 - $256.47 $11.6 Million - $12.8 Million	-50,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$232.65 - $254.58 $12.8 Million - $14 Million	-55,000 Reduced 52.38%	50,000 $12.2 Million
Q1 2021 May 17, 2021	BUY	$232.09 - $256.88 $13.9 Million - $15.4 Million	59,936 Added 133.0%	105,000 $25.5 Million
Q4 2020 Feb 16, 2021	BUY	$221.92 - $245.94 $5.56 Million - $6.16 Million	25,064 Added 125.32%	45,064 $11.3 Million
Q3 2020 Nov 16, 2020	BUY	$215.77 - $276.76 $1.73 Million - $2.21 Million	8,000 Added 66.67%	20,000 $4.65 Million
Q2 2020 Aug 14, 2020	BUY	$219.9 - $263.41 $2.64 Million - $3.16 Million	12,000 New	12,000 $2.87 Million

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.